These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 4566543)

  • 21. [Hepatic function monitoring during tuberculotherapy (author's transl)].
    Pageaux JF; Duperray B; Dubois M; Pacheco H; Pacheco Y; Brun J; Perrin-Fayolle M; Kofman J
    Therapie; 1979; 34(4):505-13. PubMed ID: 531782
    [No Abstract]   [Full Text] [Related]  

  • 22. [Are there liver protective drugs really?].
    Mincis M
    Rev Assoc Med Bras (1992); 1992; 38(1):55. PubMed ID: 1307060
    [No Abstract]   [Full Text] [Related]  

  • 23. Ciprofloxacin in the management of pulmonary tuberculosis in the face of hepatic dysfunction.
    Yew WW; Chau CH; Wong PC; Lee J; Wong CF; Cheung SW; Chan CY; Cheng AF
    Drugs Exp Clin Res; 1995; 21(2):79-83. PubMed ID: 7555613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alcoholic hepatic impairment complicating treatment with hepatotoxic antituberculosis drugs.
    Tiwari VK
    J Indian Med Assoc; 1996 Sep; 94(9):347-8. PubMed ID: 9019083
    [No Abstract]   [Full Text] [Related]  

  • 25. [The impact of antituberculosis drugs upon liver function in patients with positive HBVM].
    Chen GQ
    Zhonghua Jie He He Hu Xi Za Zhi; 1989 Apr; 12(2):89-90, 126. PubMed ID: 2791129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Side effects and toxicity of ethionamide and prothionamide.
    Tala E; Tevola K
    Ann Clin Res; 1969 May; 1(1):32-5. PubMed ID: 5350768
    [No Abstract]   [Full Text] [Related]  

  • 27. [Use of Astragalus dasyanthus in lesions of the liver in patients with pulmonary tuberculosis].
    Skakun NP; Blikhar EI; Oleĭnik AN
    Vrach Delo; 1988 Jun; (6):51-4. PubMed ID: 3420913
    [No Abstract]   [Full Text] [Related]  

  • 28. [Assessment of hepatotoxicity of antitubercular drugs in patients with pulmonary tuberculosis abusing alcohol].
    Grymiński J; Lyczewska J; Styszewska H; Walczak J
    Gruzlica; 1969 Aug; 37(8):749-57. PubMed ID: 5352301
    [No Abstract]   [Full Text] [Related]  

  • 29. [Liver damage of allergic origin during treatment with antitubercular agents].
    Kürti V; Novák O
    Cas Lek Cesk; 1968 Jun; 107(26):780-4. PubMed ID: 5661073
    [No Abstract]   [Full Text] [Related]  

  • 30. Are antitubercular drugs prescribed correctly and scientifically?
    Sahoo RC
    J Assoc Physicians India; 1994 Apr; 42(4):349-50. PubMed ID: 7860579
    [No Abstract]   [Full Text] [Related]  

  • 31. [Functional state of the liver in patients with pulmonary tuberculosis during treatment with chemopreparations of the 2d series].
    Vasilik GV
    Probl Tuberk; 1968; 46(8):43-7. PubMed ID: 5709113
    [No Abstract]   [Full Text] [Related]  

  • 32. [Tuberculostatic preparation tolerance in elderly patients with a chronic course of pulmonary tubercuosis and concomitant diseases].
    Utkin VV; Mikheeva LP; Poleshchuk AK; Krylova NP
    Probl Tuberk; 1980 Sep; (9):42-5. PubMed ID: 7422656
    [No Abstract]   [Full Text] [Related]  

  • 33. [Drug-induced hepatitis in pulmonary tuberculosis patients].
    Koriakin VIa; Sokolova GB; Ziia AV; Zeliger LR; Glik MS
    Vrach Delo; 1984 May; (5):60-2. PubMed ID: 6741089
    [No Abstract]   [Full Text] [Related]  

  • 34. [Liver function and antitubercular agents. Results of a polycentric study with various chemo-antibiotic combinations].
    Grassi C; Mainardi L; Pasquariello G; Bissanti A; Luvarà A; Pozzi E
    G Ital Chemioter; 1973; 20(1-4):1-14. PubMed ID: 4619078
    [No Abstract]   [Full Text] [Related]  

  • 35. [Comparative evaluation of several functional tests of the liver in patients with pulmonary tuberculosis with side-reactions to tuberculostatic preparations].
    Kaminskaia GO; Karachunskiĭ MA; Kolosovskaia VP
    Ter Arkh; 1969 Nov; 41(11):75-9. PubMed ID: 5384752
    [No Abstract]   [Full Text] [Related]  

  • 36. [Tolerance to antitubercular drugs in patients with tuberculosis complicated by peptic ulcer and gastric resection].
    Petrenko VM
    Klin Med (Mosk); 1978 Dec; 56(12):29-35. PubMed ID: 739743
    [No Abstract]   [Full Text] [Related]  

  • 37. [On the problem of chronic liver damage following drug therapy of tuberculosis].
    Petera V; Klapálek D; Paichl P; Pecený A
    Dtsch Z Verdau Stoffwechselkr; 1965 Oct; 25(4):250-2. PubMed ID: 5888913
    [No Abstract]   [Full Text] [Related]  

  • 38. [Correction of adverse reactions in antimicrobial therapy of respiratory tract tuberculosis].
    Sukhanov DS; Kovalenko AL; Petrov AIu; Romantsov MG; Rybalkin SB
    Antibiot Khimioter; 2008; 53(5-6):51-7. PubMed ID: 19069183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The clinico-immunological variants of drug-induced toxic hepatitis in pulmonary tuberculosis patients].
    Frolov VM; Peresadin NA; Petrunia AM
    Probl Tuberk; 1993; (6):17-9. PubMed ID: 8290522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effectiveness of S-adenosylmethionine (SAM) in the treatment of chronic liver diseases].
    Silvi G; Rina D; Giannelli G
    Clin Ter; 1980 Feb; 92(3):241-50. PubMed ID: 7449310
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.